Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains-Reference-Cited by-同舟云学术

Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains

Published:2002-01 Issue:2 Volume:277 Page:1576-1585
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Brignola Perry S.,Lackey Karen,Kadwell Sue H.,Hoffman Christine,Horne Earnest,Carter H. Luke,Stuart J. Darren,Blackburn Kevin,Moyer Mary B.,Alligood Krystal J.,Knight Wilson B.,Wood Edgar R.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference45 articles.

1. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

2. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.

3. Epidermal growth factor-related peptides and their receptors in human malignancies

4. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

5. The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of mutationally activated HER2;Chemical Biology & Drug Design;2022-08-27

2. Comparative expression of soluble, active human kinases in specialized bacterial strains;PLOS ONE;2022-04-19

3. Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-);European Journal of Medicinal Chemistry;2022-01

4. Angiogenesis Inhibitors;Burger's Medicinal Chemistry and Drug Discovery;2021-04-28

5. Pyrrole derivatives as potential anti-cancer therapeutics: synthesis, mechanisms of action, safety;Journal of Drug Targeting;2019-12-18